4-amino-6-(4-methylphenyl)pyridazin-3(2{H})-one, 95.0%, 2.5g

6-Fluoro-3-methyl-1H-indazole, 95.0%, 25g

Ethyl pyrrolo[2,1-f][1,2,4]triazine-7-carboxylate, 97%, 50mg

2-Pyridin-4-yl-thiazole-4-carboxylic acid, 95.0%, 25g

1-Bromo-4,4,4-trifluorobutane, 98.0%, 5g

N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide, 95.0%, 10g

3,3''-Dihydroxy-[1,1':4',1''-terphenyl]-4,4''-dicarboxylic acid, 95%, 250mg

Anti-Perlecan Monoclonal Antibody (HK-102)1vial

1-(6-Ethoxy-2-methylsulfanyl-pyrimidin-4-yl)-piperidin-4-ol, 95.0%, 250mg

2-((Tert-butoxycarbonyl)amino)-3-(4-methyl-1H-indol-3-yl)propanoic acid, 95+%, 1g

trans-1-Methyl-4-carboxy-5-(3-pyridyl)-2-pyrrolidinone>95.0%(GC)(T)100mg

(3-Pyrazol-1-ylmethyl-phenyl)-acetonitrile, 95.0%, 1g

19-Bromononadecanoic acid, 97%, 5g